dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


Publication year:
All
1 - 10 out of 26Page size: 10
Sort by: Title
  1. Published

    Triptans and CGRP blockade: impact on the cranial vasculature

    Benemei, S., Cortese, F., Labastida-Ramírez, A., Marchese, F., Pellesi, L., Romoli, M., Vollesen, A. L., Lampl, C., dlt446, dlt446 & School of Advanced Studies of the European Headache Federation (EHF-SAS), S. O. A. S. O. T. E. H. F. (., 10 Oct 2017, In: Journal of Headache and Pain. 18, 7 p., 103.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

    Al-Karagholi, M. A., Hansen, J. M., Severinsen, J., Jansen-Olesen, I. & dlt446, dlt446, 23 Aug 2017, In: Journal of Headache and Pain. 18, 9 p., 90.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Serotonergic mechanisms in the migraine brain: a systematic review

    Christensen, M. D., Christensen, C. E., Hougaard, A., Hansen, H. D., Knudsen, Gitte Moos & dlt446, dlt446, Mar 2017, In: Cephalalgia : an international journal of headache. 37, 3, p. 251-264 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    Tepper, S., dlt446, dlt446, Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D. & Lenz, R., 2017, In: Lancet Neurology. 16, 6, p. 425-434

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Prevalence and risk of migraine in patients with rosacea: A population-based cohort study

    Egeberg, A., dlt446, dlt446, Gaist, D., Gislason, Gunnar Hilmar & Thyssen, Jacob Pontoppidan, Mar 2017, In: Journal of the American Academy of Dermatology. 76, 3, p. 454-458 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients

    Guo, S., Vollesen, A. L. H., Hansen, Y. B. L., Frandsen, E., Andersen, M. R., Amin, F. M., Fahrenkrug, J., Olesen, Jes & dlt446, dlt446, Feb 2017, In: Cephalalgia : an international journal of headache. 37, 2, p. 136-147 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine

    Guo, S., Vollesen, A. L. H., Hansen, R. D., Esserlind, A., Amin, F. M., Christensen, A. F., Olesen, Jes & dlt446, dlt446, Feb 2017, In: Cephalalgia : an international journal of headache. 37, 2, p. 125-135 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    PACAP38 in human models of primary headaches

    Ashina, H., Guo, S., Vollesen, A. L. H. & dlt446, dlt446, 2017, In: Journal of Headache and Pain. 18, 9 p., 110.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    PACAP38 dose-response pilot study in migraine patients

    Vollesen, A. L. H., Guo, S. & dlt446, dlt446, 15 Apr 2017, In: Cephalalgia : an international journal of headache. 37, 4, p. 391-395 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    PACAP38: Emerging Drug Target in Migraine and Cluster Headache

    Vollesen, A. L. H. & dlt446, dlt446, 2017, In: Headache. 57, S2, p. 56-63

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 Next

ID: 920785